URGN
UroGen Pharma Ltd.
$29.46
+$0.57(+1.97%)
55
Overall
40
Value
66
Tech
60
Quality
Market Cap
$1.38B
Volume
600.04K
52W Range
$3.42 - $30.45
Target Price
$36.11
Key Metrics Overview
| Market Cap | $1.38B | P/E Ratio | N/A |
| 52W High | $30.45 | 52W Low | $3.42 |
| Div Yield | N/A | Payout Ratio | N/A |
| EPS Growth 3Y | 12.8% | 52W Position | 96.3% |
| Overall Score | 55 | Value Score | 40 |
| Quality Score | 60 | Technical Score | 66 |
Growth Analysis
| EPS Current Est | $-0.98 | EPS Next Est | $1.4 |
| EPS Growth Est | N/A | DPS Growth 3Y | N/A |
Revenue (5Y)
EBITDA (5Y)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | URGN | $29.46 | +2.0% | 600.04K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |